Tens of millions of people around the world are desperately trying to get their hands on a potentially life-saving coronavirus vaccine. But a group of irate private-sector doctors in Italy is appealing to the country’s health ministry to avoid having to take the Covid-19 shot it’s offered them: the AstraZeneca Plc inoculation, which they believe is less effective.
Their objection speaks to the growing backlash in Europe against the vaccine co-developed by Astra and the University of Oxford. Professionals working in Italy’s public-sector health system received vaccines from Pfizer Inc. and Moderna Inc.—both shown to be more than 90% effective—and the private-sector doctors are angry at being given what, in their view, is a second-class shot. “It’s not that we’re acting like spoiled children,” says Paolo Mezzana, a plastic surgeon who’s the spokesperson for a group of about 3,500 private specialists. “We’re not against AstraZeneca for the sake of it, but we know that with their vaccine, it takes longer to get a complete immunization. We are not class B doctors.”
Rejection of its vaccine in Europe is the latest in a string of problems for Astra. After a bitter public fight between the company and the European Union over supply shortages in January led regulators to tighten controls on exports outside Europe, the bloc now faces issues over consumer acceptance for the doses it does have. Following a study showing efficacy was considerably reduced against a variant first identified in South Africa, the rollout of Astra’s shot there was temporarily halted. A lack of data on its effectiveness in older adults and questions about optimal dosing intervals haven’t helped.
Denne historien er fra March 01, 2021-utgaven av Bloomberg Businessweek.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 01, 2021-utgaven av Bloomberg Businessweek.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers